参考文献/References:
[1] ALZHRANI G, SIVAKUMAR W, PARK MS, et al. Delayed complications after transsphenoidal surgery for pituitary adenomas [J].World Neurosurg, 2018, 109: 233-241.
[2] COTE DJ, ALZAREA A, ACOSTA MA, et al. Predictors and rates ofdelayed symptomatic hyponatremia after transsphenoidal surgery: asystemastic review [J]. World Neurosurg, 2016, 88: 1-6.
[3] YUEN KCJ, AJMAL A, CORREA R, et al. Sodium perturbationsafter pituitary surgery [J]. Neurosurg Clin N Am, 2019, 30(4): 515524.
[4] LIN KZ, ZENG R, MU SW, et al. Novel nomograms to predict delayed hyponatremia after transsphenoidal surgery for pituitary adenoma[J]. Front Endocrinol (Lausanne), 2022, 13: 900121.
[5] LAMAS C, DEL POZO C,VILLABONA C. Clinical guidelines formanagement of diabetes insipidus and syndrome of in appropriateantidiuretic hormone secretion after pituitary surgery [J]. EndocrinolNutr, 2014, 61(4): e15-24.
[6] RAJARATNAM S, JEYASEELAN L, RAJSHEKHAR V. Delayedhyponatremia following surgery for pituitary adenomas: an underrecognized complication [J]. Neurol India, 2020, 68(2): 340-345.
[7] THAKUR JD, CORLIN A, MALLARI RJ, et al. Pituitary adenomasin older adults (≥65 years): 90-day outcomes and readmissions: a10-year endoscopic endonasal surgical experience [J]. Pituitary,2021, 24(1): 14-26.
[8] LEE CC, WANG YC, LIU YT, et al. Incidence and factors associatedwith postoperative delayed hyponatremia after transsphenoidalpituitary surgery: ameta-analysis and systematic review [J]. Int JEndocrinol, 2021, 2021: 6659152.
[9] PENG Y, WANG M, GU Y, et al. delayed hyponatremia after neuroendoscopic transnasal transsphenoidal surgery for pituitary adenoma[J]. Clin J Neurosurg, 2020, 17(2): 125-129.彭 雍，王 明，顾 晔，等. 神经内镜经鼻蝶窦垂体腺瘤切除术后的迟发性低钠血症[J]. 中国临床神经外科杂志，2020，17（2）：125-129.
[10] YOON HK, LEE HC, KIM YH, et al. Predictive factors for delayedhyponatremia after endoscopic transsphenoidal surgery in patientswith nonfunctioning pituitary tumors: aretrospective observationalstudy [J]. World Neurosurg, 2019, 122: e1457-e1464.
[11] HUANG Y, WANG M, WU J, et al. Risk factors for delayed postoperative hyponatremia in patients with non-functioning pituitaryadenomas undergoing transsphenoidal surgery: a single-institutionstudy [J]. Front Neurol, 2022, 13: 945640.
[12] TANAKA H, NISHIMURA F, NAKASE K, et al. Impact of surgicalfactors on delayed hyponatremia in patients with nonfunctioningpituitary adenoma after endonasal endoscopic transsphenoidalprocedure [J]. Endocrine, 2022, 78(2): 354-362.
[13] COLE TS, JAHNKE H, GODZIK J, et al. Use of a wristmounted device for continuous outpatient physiologic monitoring after transsphenoidal surgery: a pilot study [J]. Pituitary, 2019, 22(2): 156162.
[14] TOMITA Y, KUROZUMI K, INAGAKI K, et al. Delayed postoperative hyponatremia after endoscopic transsphenoidal surgery for pituitary adenoma [J]. Acta Neurochir(Wien), 2019, 161(4): 707-715.
[15] LIN K, LU L, PEI Z, et al. Predictive factors for delayed hyponatremia after transsphenoidal surgery in patients with pituitary adenomas [J]. Endocr Connect, 2022, 11(1): e210497.
[16] HUANG Y, WANG M, WU J, et al. Risk factors for delayed postoperative hyponatremia in patients with non-functioning pituitaryadenomas undergoingtranssphenoidal surgery: a single-institutionstudy [J]. Front Neurol, 2022, 13: 945640.
[17] DAI YQ, ZHOU LY, YU H, et al. Risk factors for delayed hyponatremia in patients with pituitary adenoma after surgery throughtranssphenoidal approach [J]. Chin J Clin Neurosurg, 2022, 27(5):357-362.代永庆，周林裕，于 泓，等. 垂体腺瘤经蝶窦入路术后继发迟发性低钠血症的危险因素[J]. 中国临床神经外科杂志，2022，27（5）：357-362.
[18] HONG YG, KIM SH, KIM EH. Delayed hyponatremia after transsphenoidal surgery for pituitary adenomas: asingle institutional experience [J]. Brain Tumor Res Treat, 2021, 9(1): 16-20.
[19] LIN K, LI J, LU L, et al. Diaphragmasellae sinking can predict theonset of hyponatremia after transsphenoidal surgery for pituitaryadenomas [J]. J Endocrinol Invest, 2021, 44(11): 2511-2520.
[20] PATEL KS, SHU CHEN J, YUAN F, et al. Prediction of post-operative delayed hyponatremia after endoscopic transsphenoidal surgery[J]. Clin Neurol Neurosurg, 2019, 182: 87-91.
[21] VOGLIS S, VAN NIFTRIK CHB, STAARTJES VE, et al. Feasibilityof machine learning based predictive modelling of postoperative hyponatremia after pituitary surgery [J]. Pituitary, 2020, 23(5): 543551.
[22] Lin KZ, ZENG R, MU SW, et al. Novel nomograms to predict delayed hyponatremia after transsphenoidal surgery for pituitary adenoma[J]. Front Endocrinol (Lausanne), 2022, 13: 900121.
[23] LI FD, MIAO FA, LU Y. Feasibility study of an interpretable machine based model to predict postoperative delayed hyponatremia inpituitary adenoma patients [J]. J Xuzhou Med University, 2023, 43(3): 225-229.李峰达，苗发安，陆 岳. 基于可解释机器模型预测经碟垂体瘤术后迟发性低钠血症的可行性研究[J]. 徐州医科大学学报，2023，43（3）：225-229.
[24] ROSER P, MENDE KC, DIMITRIADIS GK, et al. The potential ofself-assessment and associated factorsfor delayed symptomatichyponatremia following transsphenoidal surgery: a single centerexperienc [J]. J Clin Med, 2022, 12(1): 306.
[25] WINOGRAD D, STAGGERS KA, SEBASTIAN S, et al. An effectiveand practical fluid restriction protocol to decrease the risk of hyponatremia and readmissions after transsphenoidal surgery [J]. Neurosrgery, 2020, 87(4): 761-769.
[26] PEREZ-VEGA C, TRIPATHI S, DOMINGO RA, et al. Fluid restriction after transsphenoidal surgery for the prevention of delayedhyponatremia: a systematic review and meta-analysis [J]. EndocrPract, 2021, 27(9): 966-972.
[27] YU S, TAGHVAEI M, REYES M, et al. Delayed symptomatic hyponatremia in transsphenoidal surgery: systematic review and metaanalysis of its incidence and prevention with water restriction [J].Clin Neurol Neurosurg, 2022, 214: 107166.
[28] TOSAKA M, YAMAGUCHI R, ITABASHI Y, et al. Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of in appropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery:recovery of measured osmolality [J]. Heliyon, 2022, 8(10): e10966.
相似文献/References:
[1]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[2]王国良 高 寒 张小鹏 公方和 李天栋.89例垂体腺瘤的手术治疗体会[J].中国临床神经外科杂志,2016,(07):435.[doi:10.13798/j.issn.1009-153X.2016.07.016]
[3]张海红 马 磊 张 威 郭 康 衡立君 贾 栋.垂体腺瘤MRI特征与视觉功能损害的关系分析[J].中国临床神经外科杂志,2016,(01):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
ZHANG Hai-hong,MA Lei,ZHANG Wei,et al.Analysis of MRI characteristics and visual function in patient with pituitary adenomas[J].,2016,(01):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
[4]线春明 张 强 杨 鹏.垂体脓肿的诊治分析：附3例报告并文献复习[J].中国临床神经外科杂志,2016,(01):38.[doi:10.13798/j.issn.1009-153X.2016.01.013]
[5]王先祥 张义泉 李庆新 王 斌 肖 瑾 张 科.经单鼻孔蝶窦入路神经内镜下切除垂体腺瘤[J].中国临床神经外科杂志,2015,(12):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
WANG Xian-xiang,ZHANG Yi-quan,LI Qing-xin,et al.Endoscopic endonasal transsphenoidal surgery for pituitary adenomas[J].,2015,(01):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
[6]马 涛 徐 韬.经蝶入路内镜手术与显微手术治疗垂体腺瘤疗效的Meta分析[J].中国临床神经外科杂志,2015,(12):748.[doi:10.13798/j.issn.1009-153X.2015.12.015]
[7]雷 霆.注重基础训练和知识更新，不断提高垂体腺瘤诊疗水平[J].中国临床神经外科杂志,2015,(10):577.[doi:10.13798/j.issn.1009-153X.2015.10.001]
[8]闫 进 李 松 杨 辉.1H-MRS对卵泡刺激素免疫阳性垂体腺瘤的诊断和预后评估的价值[J].中国临床神经外科杂志,2015,(10):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
YAN Jin,LI Song,YANG Hui..Value of 1H-MRS to diagnosis and assessment of prognoses in patients with non-functioning gonadotroph adenomas[J].,2015,(01):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
[9]甘志强 龚 杰 姚国杰 张 戈 黄 成 秦 汉 陈大瑜 马廉亭.PACS系统影像测量在经鼻蝶入路手术治疗鞍区病变中的价值[J].中国临床神经外科杂志,2015,(08):463.[doi:10.13798/j.issn.1009-153X.2015.08.006]
GAN Zhi-qiang,GONG Jie,YAO Guo-jie,et al.Value of measuring the anatomic markers related to operation with PACS software to transsphenoidal surgery for sellar lesions[J].,2015,(01):463.[doi:10.13798/j.issn.1009-153X.2015.08.006]
[10]夏为民 邵耐远 唐 科.神经内镜辅助经鼻蝶入路手术治疗急性垂体腺瘤卒中[J].中国临床神经外科杂志,2015,(07):437.[doi:10.13798/j.issn.1009-153X.2015.07.020]
[11]王亚平 贾晓雄 王 珺 王林林 谭溢涛 马德得 夏鹤春.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J].中国临床神经外科杂志,2016,(03):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
WANG Ya-ping,JIA Xiao-xiong,WANG-Jun,et al.Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J].,2016,(01):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
[12]王 璨 喻军华 黄锦峰 陈志勇 刘 斌 袁学刚 吴新宇.经鼻蝶入路显微手术切除垂体腺瘤36例[J].中国临床神经外科杂志,2015,(09):547.[doi:10.13798/j.issn.1009-153X.2015.09.012]
[13]苏卢海 张世渊 胡昌辰 沈 波.神经导航辅助内镜下经鼻蝶入路手术治疗垂体腺瘤的疗效观察[J].中国临床神经外科杂志,2015,(09):549.[doi:10.13798/j.issn.1009-153X.2015.09.013]
[14]郑 涛 吕文海 陈 隆 王 元 贺世明 高国栋.经鼻蝶入路内镜下切除垂体腺瘤术后脑脊液漏的治疗[J].中国临床神经外科杂志,2017,(01):46.[doi:10.13798/j.issn.1009-153X.2017.01.018]
[15]毋江 杨红利 解旭鹏 王甲光.经鼻蝶入路垂体腺瘤切除术后严重颅内感染合并脑积水2例[J].中国临床神经外科杂志,2017,(10):734.[doi:10.13792017.09/j.issn.1009-153X.2017.10.025]
[16]郭爱顺 陈寿仁 林瑞生.内镜下经蝶入路手术切除垂体大腺瘤80例[J].中国临床神经外科杂志,2018,(01):31.[doi:10.13798/j.issn.1009-153X.2018.01.011]
[17]李承科 何 琴 唐 辉 冯 浩 付安辉.垂体腺瘤术后外周血T淋巴细胞亚群及血清MMP-9水平的变化[J].中国临床神经外科杂志,2018,(02):87.
LI Chengke,HE Qin,TANG Hui,et al.Effects of neuroendoscope-assisted surgery via single-nostril transsphenoidal approach for pituitary adenomas on the levels of peripheral blood T lymphocyte subsets and serum MMP-9[J].,2018,(01):87.
[18]赵彬芳 贺世明 李明娟 曹娅妮 杨丽辉 郑 涛.神经内镜经鼻蝶垂体腺瘤日间手术12例临床分析[J].中国临床神经外科杂志,2018,(12):811.[doi:10.13798/j.issn.1009-153X.2018.12.018]
[19]潘金玉.1例垂体腺瘤术后颅内出血病人的康复护理[J].中国临床神经外科杂志,2019,(06):369.[doi:10.13798/j.issn.1009-153X.2019.06.017]
[20]张溢华、谭 杨、王 昊、陈立朝、贺绪智、梁 鸿、许民辉、徐伦山.游离中鼻甲粘膜瓣在经鼻蝶入路神经内镜手术切除垂体腺瘤后鞍底重建中的应用…[J].中国临床神经外科杂志,2019,(07):390.[doi:10.13798/j.issn.1009-153X.2019.07.003]
ZHANG Yi-hua,TAN Yang,WANG Hao,et al.Application of free middle turbinate mucosal flaps to reconstruction of sellar floors in endoscopic transnasal transsphenoidal surgery in patients with pituitary adenomas[J].,2019,(01):390.[doi:10.13798/j.issn.1009-153X.2019.07.003]